Paper
7 September 2023 New uric acid excretory drugs research progress in the treatment of hyperuricemia
Yuqi Huang
Author Affiliations +
Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 1278935 (2023) https://doi.org/10.1117/12.2692615
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom
Abstract
With the development of the national economy and changes in people's living habits and dietary structures, diseases caused by high concentrations of uric acid (UA) are becoming more frequent in daily life. Hyperuricemia, in particular, is on the rise and affecting younger individuals. Although UA excretory drugs are available, they have low efficacy and significant side effects. Therefore, the search for UA-lowering drugs is crucial. This paper aims to introduce the pathological mechanism of hyperuricemia and the UA excretory drugs that have been marketed and tested and to briefly review their therapeutic effects and limitations. We will analyze new UA excretory drugs in terms of their mechanism of action, clinical study results, and safety to provide new ideas and feasible ways for the development of new UA-lowering drugs and the treatment of hyperuricemia in the future.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yuqi Huang "New uric acid excretory drugs research progress in the treatment of hyperuricemia", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 1278935 (7 September 2023); https://doi.org/10.1117/12.2692615
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Proteins

Safety

Diseases and disorders

Liver

Kidney

Magnesium

Mode conditioning cables

Back to Top